{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:03:31Z","timestamp":1790269411869,"version":"4.1.0"},"reference-count":81,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To critically review the current pharmacologic treatment landscape for epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), focusing on clinical pharmacology, therapeutic evolution, and emerging challenges of EGFR-targeted therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources<\/jats:title>\n                    <jats:p>Peer-reviewed literature in PubMed, Web of Science, and Embase databases (January 2000 to June 2026) was searched using keywords including \u201cEGFR-mutant NSCLC,\u201d \u201cEGFR-TKIs,\u201d \u201cdrug resistance,\u201d \u201cartificial intelligence,\u201d and \u201cprecision oncology.\u201d Reference lists and clinical trial registries were also screened.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Summary<\/jats:title>\n                    <jats:p>This review systematically examines clinical misconceptions surrounding EGFR-targeted therapies, focusing on three cognitive biases that undermine precision implementation: overgeneralization of trial efficacy to unselected populations; oversimplified sequencing that ignores clonal selection trade-offs (second-generation TKIs reduce subsequent osimertinib Progression-free survival (PFS) by \u223c2 months); and inflated efficacy perceptions for Ex20ins inhibitors (aggregate objective response rate (ORR) masks far-loop responses of only 22%) and MET combinations (true benefit confined to high-expression subgroup). We also critically evaluate artificial intelligence's translational potential in molecular subtyping, resistance prediction, and drug discovery, alongside the data, modeling, and validation barriers limiting its clinical deployment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite the expanding therapeutic armamentarium, clinically meaningful precision remains constrained by persistent misconceptions and translational bottlenecks. Artificial intelligence (AI) offers enabling potential, but its integration requires standardized data infrastructures, dynamic modeling, and prospective validation. AI outputs should currently be interpreted as hypothesis-generating tools, not replacements for clinical judgment. Continued collaborative efforts are warranted to refine treatment sequencing and translate emerging technologies into measurable patient benefit.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552261488860","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:54:35Z","timestamp":1790074475000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["AI-Driven precision targeted therapy for EGFR-mutant non-small cell lung cancer: From therapeutic evolution and resistance mechanisms to intelligent decision systems"],"prefix":"10.1177","author":[{"given":"Fuxiang","family":"Wang","sequence":"first","affiliation":[{"name":"People's Hospital of Liaoning Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Jiang","sequence":"additional","affiliation":[{"name":"People's Hospital of Liaoning Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"People's Hospital of Liaoning Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[{"name":"People's Hospital of Liaoning Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"People's Hospital of Liaoning Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"People's Hospital of Liaoning Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8047-0285","authenticated-orcid":false,"given":"Fusheng","family":"Chi","sequence":"additional","affiliation":[{"name":"People's Hospital of Liaoning Province"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.5c00940"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2024.102058"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-026-00815-2"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102315"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08138-2"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf006"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713618"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00893"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000004016"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2023.03.003"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103935"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01592-8"},{"key":"e_1_3_4_14_2","article-title":"Hitting the right spot: advances in the treatment of NSCLC with uncommon EGFR mutations","volume":"19","author":"Sabari JK","year":"2021","unstructured":"Sabari JK, Heymach JV, Sandy B. Hitting the right spot: advances in the treatment of NSCLC with uncommon EGFR mutations. J Natl Compr Cancer Netw 2021; 19: S1\u2013S11.","journal-title":"J Natl Compr Cancer Netw"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c00875"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2024.102094"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.est.4c03088"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012374"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1109\/JBHI.2021.3133455"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218229"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115840"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-2951"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00704"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27125197"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00808-4"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34889-z"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33821"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2025.201007"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(26)00090-2"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.101073"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-4035"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70460"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-026-01751-0"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01085-z"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-022-00883-0"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218321"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030629"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.10.021"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-26-0749"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63821-2"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2072"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1677737"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001777"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.05.006"},{"key":"e_1_3_4_45_2","first-page":"100600","article-title":"Mobocertinib and bevacizumab for amivantamab-refractory lung cancer with EGFR exon 20 insertion mutation: a case report","volume":"4","author":"Kim J","year":"2023","unstructured":"Kim J, Lee Y. Mobocertinib and bevacizumab for amivantamab-refractory lung cancer with EGFR exon 20 insertion mutation: a case report. JTO Clin Res Rep 2023; 4: 100600.","journal-title":"JTO Clin Res Rep"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11769"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2025.1399"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100319"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2026.109412"},{"key":"e_1_3_4_50_2","first-page":"596080","article-title":"Exploratory identification of gene copy number cut-off for NGS-based MET amplification assessment and clinical relevance to MET inhibitor outcomes in non-small-cell lung cancer","volume":"17","author":"Liu S-YM","year":"2026","unstructured":"Liu S-YM, Xie Z, Yan L, et al. Exploratory identification of gene copy number cut-off for NGS-based MET amplification assessment and clinical relevance to MET inhibitor outcomes in non-small-cell lung cancer. Lung Cancer 2026; 17: 596080.","journal-title":"Lung Cancer"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40854-023-00483-5"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143441"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101183"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70476"},{"key":"e_1_3_4_55_2","article-title":"Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study","volume":"4","author":"Wang S","year":"2022","unstructured":"Wang S, Yu H, Gan Y, et al. Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study. Lancet Digit Health 2022; 4: e309\u2013e319.","journal-title":"Lancet Digit Health"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1109\/TMI.2025.3578995"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51630-6"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1090180"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2025.6430"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2025.108577"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.3c04479"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-025-09567-z"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-024-09553-y"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107734"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-026-00829-6"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157421"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaf338"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/pro.5257"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2024.03.014"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2023.108003"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btad465"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.34133\/csbj.0118"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.5c06704"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.4c00895"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2026.2657646"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-00909-7"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-25-0155"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-2025-1043"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bspc.2025.108890"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-026-01420-2"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-2025-1012"},{"key":"e_1_3_4_82_2","unstructured":"He J. Application of the artificial intelligence-based gene mutation prediction tool DeepGEM in patients with non-small cell lung cancer (NSCLC): a prospective multicenter randomized controlled trial. (August 31 2026) https:\/\/clinicaltrials.gov\/study\/NCT07110259 (2025)."}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552261488860","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552261488860","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552261488860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:23:07Z","timestamp":1790266987000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552261488860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":81,"alternative-id":["10.1177\/10781552261488860"],"URL":"https:\/\/doi.org\/10.1177\/10781552261488860","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"10781552261488860"}}